Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm Metastasis

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,461 public trials 502 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases

NCT00119899

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Liver Metastases, +14 more
Locations: UMC ST Radboud Nijmegen, Gelderland, Netherlands

MMC Veldhoven, North Brabant, Netherlands

UMCVU Amsterdam, North Holland, Netherlands

UMCG Groningen, Provincie Groningen, Netherlands

View Trial Details

Completed

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

NCT00055562

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

University of Southern California Norris Cancer Center Los Angeles, California, United States

UCLA Los Angeles, California, United States

St. Francis Memorial Hospital San Francisco, California, United States

View all 31 locations

View Trial Details

Completed

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

NCT00041808

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations: Scripps Stevens Cancer Division San Diego, California, United States

UCSF Cancer Center San Francisco, California, United States

Scott and White Clinic Temple, Texas, United States

Frankfurt Universtiy Frankfurt, Germany

View Trial Details

Completed

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

NCT00051779

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Highlands Oncology Group Springdale, Arkansas, United States

Bay Area Cancer Research Group Concord, California, United States

California Cancer Care, Inc. Greenbrae, California, United States

View all 38 locations

View Trial Details

Terminated

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

NCT07076550

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +21 more
Locations: Alfred Health Melbourne, Victoria, Australia

Austin Health Melbourne, Victoria, Australia

Fiona Stanley Hospital Murdoch, Western Australia, Australia

GenesisCare Murdoch Murdoch, Western Australia, Australia

View Trial Details

Terminated

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

NCT01216371

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Universitätsmedizin Charité Berlin Berlin, Germany

Franziskus Krankenhaus Berlin, Germany

Helios Klinikum Emil von Behring Berlin, Germany

university hospital of Düsseldorf Düsseldorf, Germany

View Trial Details

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Rocky Mountain Cancer Centers Aurora, Colorado, United States

St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States

View all 17 locations

View Trial Details

Terminated

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

NCT05065736

Conditions: Adenocarcinoma, Carcinoma, Metastatic Cancer, +7 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Terminated

High Dose IL-2 in Combination With Anti-PD-1

NCT03991130

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

View Trial Details

Suspended

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

NCT05475171

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details